84-3680-52　［取扱停止］BRAF35 (Breast Cancer Type 2 Susceptibility Protein-Associated Factor 35, BRCA2-Associated Factor 35, BRAF-35, BRAF 35) (Biotin) 100ul　301320-Biotin

特徴

• Mutations of the human BRCA2 gene confer susceptibility to breast cancer.
• A structural DNA binding component has been identified and is designated as BRCA2-Associated Factor 35 (BRAF35).
• There is a close association of the BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation.
• Experimental evidence suggests a role for the BRCA2/BRAF35 complex in the modulation of cell cycle progression.
• Applications:Suitable for use in Western Blot.
• Other applications not tested.
• Recommended Dilution:Western Blot: 1:500-1:1000Optimal dilutions to be determined by the researcher.
• Storage and Stability:Store product at 4°C if to be used immediately within two weeks.
• For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C.
• Aliquots are stable at -20°C for 12 months after receipt.
• Dilute required amount only prior to immediate use.
• Further dilutions can be made in assay buffer.
• For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
• Note: Applications are based on unconjugated antibody.